Negara: Inggris
Bahasa: Inggris
Sumber: MHRA (Medicines & Healthcare Products Regulatory Agency)
Nitrofurantoin
Morningside Healthcare Ltd
J01XE01
Nitrofurantoin
100mg
Oral capsule
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05011300; GTIN: 5055132714634
PACKAGE LEAFLET: INFORMATION FOR THE USER Nitrofurantoin 50mg and 100mg Capsules Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet. You may need to read it again. • If you have further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What Nitrofurantoin Capsules are and what they are used for 2. What you need to know before you take Nitrofurantoin Capsules 3. How to take Nitrofurantoin Capsules 4. Possible side effects 5. How to store Nitrofurantoin Capsules 6. Contents of the pack and other information 1. WHAT NITROFURANTOIN CAPSULES ARE AND WHAT THEY ARE USED FOR Nitrofurantoin (the active substance in Nitrofurantoin Capsules) is an antibiotic. It is used to prevent and treat infections of the bladder, kidney and other parts of the urinary tract. You must talk to a doctor if you do not feel better or if you feel worse. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE NITROFURANTOIN CAPSULES Do not take Nitrofurantoin Capsules if: • you are allergic to nitrofurantoin, other medicines containing nitrofurantoin or to any of the other ingredients of this medicine (listed in Section 6). • you have a disease of the kidneys which is severely affecting the way they work (ask your doctor if you are not sure). • you are in the final stages of pregnancy (labour or delivery) as there is a risk that it might affect the baby. • you suffer from a blood disorder called porphyria. • you are deficient in an enzyme called G6PD (glucose-6-phosphate dehydrogenase). • your child is under three months of age. • you are breast feeding a baby with suspected or known deficiency in an enzyme called G6PD (glucose-6-pho Baca dokumen lengkapnya
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Nitrofurantoin 100mg Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 100 mg of Nitrofurantoin Ph Eur in macrocrystalline form. Excipient with known effect: Each capsule contains 162mg lactose monohydrate. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Yellow coloured free flowing granules filled in hard gelatine capsule with white body printed with “100” in black and yellow cap printed with “NTF” in black. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Nitrofurantoin is indicated for the treatment of and prophylaxis against acute or recurrent, uncomplicated lower urinary tract infections or pyelitis either spontaneous or following surgical procedures. It is indicated in adults, children and infants over 3 months old. Nitrofurantoin is specifically indicated for the treatment of infections due to susceptible strains of Escherichia coli, Enterococci, Staphylococci, Citrobacter, Klebsiella and Enterobacter. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adults Acute Uncomplicated Urinary Tract Infections (UTIs): 50 mg four times daily for seven days. Severe chronic recurrence (UTIs): 100 mg four times daily for seven days. Long term suppression: 50-100 mg once a day. Prophylaxis: 50 mg four times daily for the duration of procedure and for three days thereafter. Paediatric population Children and Infants over three months of age Acute Urinary Tract Infections: 3mg/kg day in four divided doses for seven days. Suppressive - 1mg/kg, once a day. For children under 25kg body weight other formulations of nitrofurantoin should be considered Elderly Provided there is no significant renal impairment, in which Nitrofurantoin is contraindicated, the dosage should be that for any normal adult. See precaution and risks to elderly patients associated with long-term therapy (Section 4.8). Renal impairment Nitrofurantoin is contraindicated in patients with renal dysfunction and in patients with an eGFR Baca dokumen lengkapnya